neurocare group AG (“neurocare” or the “Company”) announced that it has received FDA clearance for the treatment of Major Depressive Disorder (MDD) in adolescents using its Apollo TMS Therapy devices and Transcranial Magnetic Stimulation (TMS).

Currently, only two oral antidepressants are FDA-approved for use in this age group, and both carry a “black box” warning—the strongest warning the FDA issues for medications—due to an increased risk of suicidal thoughts and actions, the announcement stated. These medications have an effectiveness rate of only about 35% in achieving remission, according to the announcement.

TMS offers a safe, non-invasive . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
If you are already a member, log in to your account to access this resource and more.

You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

Mental Health Services

The mental health market is defined as treatment services for mental and emotional health and psychiatric care for individuals of all ages. Mental health services are provided by a wide array of professionals, including certified counselors, psychiatrists, psychologists, neurologists, and social workers. The mental health market is facing new challenges – continued cost pressures on Medicare, Medicaid, and government programs; a shift to value-based care financing models; increased consolidation of health systems; and a push towards tech-enabled, consumer-led interventions. While these challenges may seem immense, the mental health market has experienced numerous shifts over the years from the move to managed care to increased community-based care. Organizations that can adapt to these changes are most likely to succeed.


Latest Resources
See All
California awarded $1.18 billion in grant funding for 66 behavioral health infrastructure projects across 130 facilities to expand residential and crisis treatment capacity statewide. The projects are expected to add 2,554 residential and inpatient beds and 4,273 outpatient treatment slots. The funding is part of the Bond Behavioral Health Continuum Infrastructure Program (Bond BHCIP) Round 2: Unmet Needs, created through Proposition 1, which was approved in 2024. Proposition 1 authorized $6.4 billion in bond funding… Read